Latest Headlines

  1. Emerson Streamlines Life Sciences Recipe Creation For Faster Time To Market 3/9/2026
  2. LOTTE BIOLOGICS Signs Letter Of Intent (LOI) For Strategic Collaboration With U.S.-Based Multinational Company That Has Also Presence And Operation In Japan And Taiwan 3/6/2026

    LOTTE BIOLOGICS (CEO James Park) announced that it has signed a Letter of Intent (LOI) for strategic business collaboration with a multinational biotechnology company headquartered in the United States. 

  3. LOTTE BIOLOGICS Signs Strategic Partnership Agreement With U.S.-Based Asimov 3/6/2026

    LOTTE BIOLOGICS (CEO James Park) on March 13th that it has signed a Memorandum of Understanding (MOU) with Asimov, a company headquartered in Boston, Massachusetts, to collaborate in the Contract Development and Manufacturing Organization (CDMO) business.

  4. Minaris Launches AgentSCREEN Adventitious Virus Detection By NGS To Simplify Viral Safety Testing For Cell Banks And Cell-Based Samples 3/4/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN Adventitious Virus Detection by Next Generation Sequencing (NGS).

  5. Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team 3/3/2026

    Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.

  6. Novartis Announces New Radioligand Therapy Manufacturing Facility In Denton, Texas 2/26/2026

    Novartis, a leading global innovative medicines company, today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas. 

  7. Andelyn Biosciences To Apply the AAV Curator® Platform To Manufacture Clinical Grade AAV For Drake Rayden Foundation For The Treatment Of Nonketotic Hyperglycinemia 2/25/2026

    Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by Drake Rayden Foundation to apply the AAV Curator® Platform to manufacture clinical grade AAV for the Treatment of Nonketotic Hyperglycinemia (NKH), a rare, inherited metabolic genetic disorder caused by a mutation in the GLDC gene.

  8. Nu-Tek BioSciences Reinforces Global Supply Leadership With Halal Certification Renewal 2/25/2026

    Nu-Tek BioSciences, the industry leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it has successfully renewed its Halal certification from The Islamic Food and Nutrition Council of America (IFANCA).

  9. Nu-Tek BioSciences To Highlight Animal-Origin-Free Peptones, Supply Chain Strength At DCAT Week 2026 2/25/2026

    Nu-Tek BioSciences, the market leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it will participate in the upcoming Drug, Chemical and Associated Technologies (DCAT) Week 2026, hosted March 23–26 in New York City. 

  10. Bora Pharmaceuticals And GSK Sign $250M Five Year Global Manufacturing Contract 2/24/2026

    This renewed collaboration reinforces the long-standing relationship between the two companies and expands the partnership, allowing GSK access to multiple sites within the Bora network, including its newest OSD site in Maple Grove, Minnesota.